InsidersTradesSigma
Track the ST凯利 stock price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, ST凯利 has published 1 insider filings. Market capitalisation: €4bn. The latest transaction was filed on 21 January 2025 (Purchase). Among the most active insiders: 袁征. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
ST凯利 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and distribution of pharmaceutical products.